Studies
A Model for Predicting Response to PD-1 Inhibitors in NSCLC
A Model for Predicting Response to PD-1 Inhibitors in NSCLC
Request Access
Overview
Selected Publications (1)
Tumor Characteristics Associated with Benefit from Pembrolizumab in Advanced Non–Small Cell Lung Cancer
S. Hu-Lieskovan, A. Lisberg, J. Zaretsky, et al.. (2019). Clinical Cancer Research. Cited 62 times.
https://doi.org/10.1158/1078-0432.CCR-18-4275
